CD44 and cancer: Because CD44 lacks kinase activity, it can transduce signals via coupling its intracellular domain to adaptor proteins or kinases such as PI3K, NFkB, or CREB [113] and target downstream genes Survivin, Cortactin, and TGF-b2 all of which are related to cancer cell invasion [18, 114–116].